More on EIKN

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (8.6 Score)

Upcoming Events

- Earnings (12/2/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

(NQ:EIKN)
Delayed: 5.54 -1.72 (23.69%)
Prev. Close $7.26  
Open$7.20 
52 Wk High$ 
52 Wk Low$ 
Day High$7.44 
Day Low$5.44 
P/E N/A  
EPS$ 
Volume965,924 

Friends, Peers and Foes (?): MRK (more...)

Oct 26, 2026 06:03 AM Eikon Therapeutics shares EIK1001 lung cancer trial data at ESMO
Oct 26, 2026 06:02 AM Form 8-K Eikon Therapeutics, Inc. For: Oct 26
Oct 26, 2026 06:00 AM Eikon Therapeutics Presents Updated EIK1001 Data from TeLuRide-005 at the European Society for Medical Oncology Congress
Oct 23, 2026 09:15 AM Form 8-K Eikon Therapeutics, Inc. For: Oct 23
Oct 23, 2026 09:15 AM Eikon Therapeutics Presents Data from PARP1-Selective and WRN Helicase Programs at the European Society for Medical Oncology Congress
Oct 18, 2026 06:05 PM Eikon Therapeutics Announces Availability of Seven Abstracts for Presentation at the European Society for Medical Oncology Congress
Oct 16, 2026 06:08 AM H.C. Wainwright Starts Eikon Therapeutics Inc. (EIKN) at Buy
Oct 15, 2026 08:01 AM Eikon Therapeutics files IND for prostate cancer drug EIK1006
Oct 15, 2026 08:00 AM Eikon Therapeutics Submits IND for Novel Androgen Receptor Antagonist EIK1006 in Prostate Cancer
Oct 7, 2026 11:47 AM Form SCHEDULE 13G/A Eikon Therapeutics, Inc. Filed by: FMR LLC
View All Articles

Entities mentioned with EIKN

View All Entities